KSS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kohl's is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has short-term momentum from the earnings beat, but the current setup is already stretched and the upside looks limited near term. I would not buy aggressively at this price; holding off is the better call.
KSS is in a short-term bullish trend after earnings, with MACD histogram positive and expanding, which confirms upward momentum. However, RSI_6 at 82.206 signals the stock is overbought, making the current entry less attractive after the recent pop. Price is near resistance at 15.28 and still below R2 at 16.422, so upside from here looks constrained while the risk of a pullback is elevated. The moving averages are converging, which suggests the trend is not yet firmly established for a durable long-term move.
["Q1 results beat expectations, with net sales of $3 billion and a much smaller GAAP net loss of $14 million.", "CEO said the company achieved its best comparable sales performance in over four years.", "Kohl's reiterated FY2026 guidance, which reduces near-term uncertainty.", "Expansion of the Sephora partnership could help attract younger customers and improve traffic.", "Hedge funds have been buying aggressively, with reported buying up 1300% over the last quarter."]
["Pre-market price is slightly down at 15.49, showing some profit-taking after the post-earnings jump.", "FY2026 guidance still calls for flat to 2% lower net and comparable sales, so growth remains weak.", "Analyst sentiment is mixed-to-negative overall, with several firms cutting targets and maintaining Sell/Underperform/Underweight views.", "Technical indicators show the stock is overbought, which raises the odds of a near-term pullback.", "A similar-pattern trend model suggests negative performance over the next week and month."]
Latest quarter: Q1 FY2026. Kohl's reported net sales of $3 billion, down 1.7% year over year, but above analyst expectations. GAAP net loss narrowed to $14 million, or $0.13 per share, improving from last year. The key positive is that comparable sales improved to the best level in over four years, but overall revenue growth is still negative and management's FY2026 guide implies sales may remain flat to down 2%, so the fundamental recovery is still early.
Analyst sentiment has improved at the margin but remains mixed overall. Gordon Haskett turned constructive and has a Buy rating with a $20 target, while Citi, BofA, JPMorgan, Goldman Sachs, and UBS remain cautious to bearish with targets mostly in the $8-$15 range. TD Cowen, Jefferies, Baird, and Evercore are neutral/hold-like, reflecting a wait-and-see stance. Wall Street’s pro view is that momentum from mid-2025 can continue and that Q1 showed progress; the con view is that Kohl's still faces weak comps, margin pressure, macro sensitivity, and execution risk before a real turnaround is proven.
